BRIMONIDINE CUTANEOUS GEL

Clinical Indication

Facial erythema of rosacea (fixed erythema not flushing)

Comments

Review after one month and discontinue if no benefit

Local guidance

Moved from simple amber status in Sept 2016

Date of classification

September 2016

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.